← Return to Video Q&A about Amyloidosis – What Patients Need to Know

Event
Video Q&A about Amyloidosis – What Patients Need to Know Event Date: June 4, 2015 | 12:00pm - 1:00pm ET
Comment receiving replies
@mvpdda

Is there any research on treating AL Amyloidosus with velcade only without the accompanying use of steroids?

Jump to this post

Replies to "Is there any research on treating AL Amyloidosus with velcade only without the accompanying use of..."
Christina Bokusky | @BokuskyChri | Jun 8, 2015

The mature and updated results of CAN2007, a phase 1/2 study of once- and twice-weekly single-agent bortezomib in relapsed AL amyloidosis by Donna Reece et al. were published in the journal Blood in 2014. Seventy patients were treated and single-agent bortezomib produced durable hematologic responses and promising long-term overall survival. This trial was registered at http://www.clinicaltrials.gov as #NCT00298766.

VIEW AND REPLY